Skip to main content
Earnings Labs
Molecular Partners AG logo

Molecular Partners AG (MOLN)

NASDAQ·Healthcare·Biotechnology

$4.12

+4.83%

Mkt Cap $183.26M

Analyst Ratings

No recent rating data.

Price Target (2 analysts)

$13.00

Range $13.00$13.00

Implied Upside

+215.5%

Consensus $13.00 vs current $4.12